Search filters

List of works by Alain Vergnenegre

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.

scientific article

A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cis

scientific article published in March 2009

A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective

scientific article published on 11 March 2015

Abstract 265: Cotargeting EGFR, STAT3 and Src-Notch pathways: a promising approach to improve the efficacy of EGFR-TKIs in the treatment of NSCLC patients

An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer.

scientific article

Anti PD-1 (nivolumab, pembrolizumab) or anti PD-L1 (atezolizumab) versus docetaxel for previously treated patients with advanced NSCLC: A meta-analysis

Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study).

scientific article

Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

scientific article published on May 2015

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

scientific article

Biomarkers in lung oncology

scientific article published on 13 May 2010

Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions

scientific article published on 23 December 2011

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.

scientific article

Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain.

scientific article published on 17 May 2011

Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505).

scientific article published on 7 June 2012

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504) ⬇️

scientific article published on July 20, 2012

Cost of lung cancer: a methodological review.

scientific article published on January 2006

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.

scientific article published on 15 August 2016

Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers

scientific article published on 24 July 2017

Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study ⬇️

scientific article published on January 1, 2011

Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial

scientific article published in May 2010

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study

scientific article

Costs, costs and more costs: which one should we use?

scientific article

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

scientific article published on 26 January 2012

Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial

scientific article published on 3 March 2016

Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC.

scientific article

Economic analyses of immune-checkpoint inhibitors to treat lung cancer

scientific article published on 11 December 2020

Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study

scientific article

Economic impact of gefitinib for refractory non-small-cell lung cancer: a Markov model-based analysis

scientific article published in July 2007

Economics of treatments for non-small cell lung cancer

scientific article

Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer

scientific article published on August 2010

Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study

scientific article

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

scientific article

Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial

scientific article published on January 2015

FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?

scientific article published on 26 July 2008

Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01).

scientific article published on 29 August 2014

Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998-2007.

scientific article published on 3 December 2010

How many drugs in the maintenance setting for non-small-cell lung cancer? For what benefit?

scientific article published on October 2013

Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small–cell lung cancers: An open phase II study using concurrent cisplatin–oral vinorelbine and radiotherapy (GFPC 08-06)

scientific article published on 22 April 2018

Indoor radon and lung cancer in France

scientific article published on 01 November 2004

L'administration d'infliximab en rhumatologie : les conséquences de la tarification à l'activité (T2A)

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

scientific article

Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04)

scientific article published on 20 November 2019

Management of elderly patients

scientific article

Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.

scientific article published in September 2005

Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study).

scientific article

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

scientific article

Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced Non-small Cell Lung Cancer: The GFPC 05-03 Study ⬇️

scientific article published on 01 February 2011

Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review

scientific article published on 17 September 2018

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)

scientific article published on 27 December 2019

Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group

scientific article published in October 2017

ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation

scientific article

Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer.

scientific article

Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.

scientific article published on 26 May 2016

Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.

scientific article published in January 2018

Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al

scientific article published on 31 October 2016

Review of economic analyses of treatment for non-small–cell lung cancer (NSCLC)

article

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study ⬇️

scientific article published on October 14, 2010

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study.

scientific article

Second-line treatments of small-cell lung cancers

scientific article published on 29 August 2017

Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapy

scientific article published on 24 September 2014

Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC).

scientific article published on August 2010

Targeted Therapies in Non–Small-Cell Lung Cancer Management: No Cost-Effective Strategies?

scientific article published on 08 September 2014

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer.

scientific article published on 18 June 2017

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

scientific article published on October 2013

Treatment of lung cancer: will financial issues become a criterion of choice?

scientific article

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

scientific article published on 16 February 2016

[Epidemiology of prostate cancer in the Limousin area]

scientific article published on 01 April 2002

Paulina is supported by:

About Paulina

Help